BCTX News and Press, BriaCell Therapeutics Corp. From 03/30/21

Clinical and pathological findings from clinical trial of the Bria-IMT™ regimen alone and in combination with immune checkpoint inhibitors in advanced breast cancer will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2021, April 10-15 and May...

XTL Biopharmaceuticals (XTLB) +93%.Second Sight Medical Products, Inc. (EYES) +50%.Fulgent Genetics, Inc. (FLGT) +32% on Q4 results.CLPS Incorporation (CLPS) +29% on FQ2 results.Sify Technologies Limited (SIFY) +26% on report of Blackstone buying minority stake.Waitr Holdings (...

FibroGen (FGEN) -25% on Q4 earnings release and after FDA to hold AdCom meet to review FibroGen, AstraZeneca's kidney drug.Comstock Mining (LODE) -19% after launching 4M-share public offering.Inseego (INSG) -16% on Q4 earnings release.RedHill Biopharma (RDHL) ...

Are These On Your List Of Penny Stocks To Buy This Week? Love it or hate it, Robinhood and the popular penny stocks on the platform continue generating attention. The app and its founders came under fire recently amid the big GameStop (NYSE: GME ) short squeeze. While ma...

BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (TSX-V:BCT) (NASDAQ: BCTX, BCTXW) (“BriaCell” or the “Company”) , a clinical-stage biotechnology company specializing in targeted immunotherapies f...